ABOUT ORGANOX:
OrganOx is a commercial stage organ technology company dedicated to developing technologies to improve outcomes for patients with acute or chronic organ failure. The company was established as a spin out of the University of Oxford in 2008 and is now part of the Terumo Group. OrganOx is a pioneer in normothermic machine perfusion (NMP). It's flagship platform, the metra®, is available for use in the U.S., Europe, Canada, and Australia. It has been utilized in over 7,000 liver transplants to date to keep donor livers in a metabolically active state outside the body enabling longer preservation times and functional assessment of the organ prior to transplant, leading to an increased number of organs available for transplant. Founded in 1921, Terumo Corporation (TSE:4543) strives to fulfill its mission of “Contributing to Society through Healthcare” by providing a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.
We are seeking a highly skilled and motivated Technology Transfer Engineer to execute the Operational elements required to successful deliver company change projects.
This will involve Creation of Change Controls (CC) and the presentation at the CC Review Board, driving and completing CC activities and ensuring successful roll out of the changes within the company.
This will be achieved by performing seamless updates to production processes & documentation whilst ensuring regulatory compliance leading to full continuity of supply. The ideal candidate will have a strong background in project management, change management, medical device manufacturing, and cross-functional collaboration (between internal teams and external partners) which will deliver results on time and within scope.
This is an on-site role in Oxford with flexibility, and occasional travel to supplier & CDMO sites.
Listed below are the key responsibilities of the role and a brief description of some of the key tasks to be performed. This list is not totally exhaustive, and the Tech Transfer Engineer will be expected to complete additional tasks reasonably requested by the Senior tech Transfer Engineer, the Continuous Improvement & New Product Introduction Manager or Senior Leadership Team.
Major Responsibilities
Under the direction of the Continuous Improvement & New Product Introduction Manager and Senior Tech Transfer Engineer, the Tech Transfer Engineer will be responsible for:
Requirements
Skills and Experience
Qualifications
Benefits
At OrganOx, we value innovation, evidence, integrity, teamwork, respect, and passion. We offer competitive compensation and comprehensive benefits, including healthcare and retirement plans. We support work-life balance and provide opportunities for ongoing professional development.
We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to age, disability, gender reassignment, marriage and civil partnership, pregnancy and maternity, race, religion or belief, sex, sexual orientation race, or any other characteristics protected by law.

Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device.
The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford.
OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford.
Conventional cold preservation involves storage of the liver at 4˚C, using a non-physiological perfusion solution that aims to minimise liver decay. By contrast, warm preservation seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells at 37˚C and providing nutrition. The liver is therefore functional during the preservation period, producing bile, metabolizing glucose and maintaining a physiological pH. This enables objective assessment of organ performance prior to transplant, extended preservation times, and the potential use of organs that are presently being discarded.